#Truvada

The prevention pills—and newer methods—have averted countless HIV cases, but they still aren’t reaching everyone who could benefit.

Requiring insurers to cover PrEP encourages homosexual behavior, promiscuity and drug use, claims a federal lawsuit by Jonathan Mitchell.

The PrEP 2-1-1 regimen offers an option to take HIV prevention pills before and after sex instead of every day.

PrEP prescriptions are supposed to be free to users now, which could go a long way toward leveling the HIV-prevention playing field.

Telemedicine is an increasingly used to provide convenient PrEP services. But are these programs following U.S. guidelines?

Under provisions of the Affordable Care Act, insurers must cover costs related to PrEP.

Currently, fewer than 1 in 10 women eligible for HIV prevention medications are taking them.

An eight-year review of medical records shows that PrEP persistence is associated with higher income and private insurance.

Previous research has shown low rates of use of HIV prevention products, but the tide could be turning.

However, the benefit would be less evident in Georgia, the state with the highest lifetime risk of acquiring HIV.

In a letter to federal officials, PrEP4All and HIV advocates demand an update on the drug patent lawsuit “United States v. Gilead.”

Every-other-month cabotegravir injections may work even better than daily pills for HIV prevention.

Starting today, the CDC recommends that clinicians prescribe pre-exposure prophylaxis to anyone who asks for it.

NoiseFilter’s latest animated HIV series explains U=U, PrEP and PEP—with help from trans activist Milan Nicole Sherry.

Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.